Freezing brain damage in its tracks: cooling drugs limit stroke injury in mice

Researchers developed a two-drug combination that induces therapeutic hypothermia in mice, significantly limiting stroke-induced brain damage. Published online on June 17, 2026, in Nature, the study details how this combination lowers metabolism and dilates blood vessels, effectively reducing the brain's oxygen demand. This approach aims to provide a critical window for intervention following ischemic strokes, where blood flow to the brain is interrupted. In the study, mice treated with the drug combination experienced a substantial reduction in lesion volume compared to control groups. The drugs work synergistically: one agent induces hypothermia by slowing cellular metabolic processes, while the other promotes vasodilation, ensuring better blood flow to the brain's periphery. This dual action is crucial for protecting brain tissue from the damaging effects of oxygen deprivation. The findings represent a promising preclinical step towards developing new therapeutic strategies for stroke patients, potentially offering a more effective and accessible treatment than current methods. Further research is planned to assess the safety and efficacy of this combination in larger animal models before human trials can be considered.